Bernstein Keeps Their Buy Rating on Novartis AG (NOVN)

TipRanks22:16 ET · Ratings

Novartis (NVS.US) has received approval from the European Commission for its important small molecule drug, which is expected to transform the treatment of early-stage breast cancer.

Novartis will continue to evaluate the long-term outcomes of NATALEE patients, including overall survival.

Zhitong FinanceNov 27 18:43 ET

European Commission Approves Products by BeiGene, GSK and Novartis

Seeking AlphaNov 27 08:41 ET

The European Commission Has Approved Novartis' Kisqali (Ribociclib) In Combination With An Aromatase Inhibitor For The Adjuvant Treatment Of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer At High Risk...

BenzingaNov 27 05:09 ET

Novartis' Early Breast Cancer Drug Gets Approval From EU Commission

MT NewswiresNov 27 01:41 ET

Octavian AG Lifts Price Target on Novartis, Maintains Hold Recommendation

MT NewswiresNov 26 09:30 ET · Ratings